SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Tharos who wrote (8689)2/12/1999 6:04:00 AM
From: Arthur Radley  Read Replies (2) | Respond to of 17367
 
For a non-intravenous application method for doxycycline you might look at ATRX. Their ATRIGEL method is being used for the treatment of peridontal disease in which they administer doxycycline in a gel form and it releases the medication in a timed released delivery. They are now working on using this delivery system to treat prostate cancer. The benefit is that the medicine is directly applied to the site of need and not delivered systematically.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News